Effects of lysophosphatidic acid receptor 1 (LPA1) antagonism on biomarkers in patients with idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF): data from a randomized phase 2 trial with BMS-986278

被引：1
|
作者：
Maher, Toby M. [1 ]
Kaminski, Naftali [2 ]
Wang, Fang [3 ]
Yarra, Tejaswi [3 ]
Elpers, Brandon [3 ]
Hu, Sarah [3 ]
Schafer, Peter [3 ]
Horan, Gerald [3 ]
机构：
[1] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA
[2] Yale Univ, Sch Med, Pulm Crit Care & Sleep Med, New Haven, CT USA
[3] Bristol Myers Squibb, Princeton, NJ USA
来源：
EUROPEAN RESPIRATORY JOURNAL | 2024年 / 64卷
关键词：
D O I：
10.1183/13993003.congress-2024.OA2860
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 33 条
  • [21] Preclinical evaluation of HL001, a novel lysophosphatidic acid 1 (LPA1) receptor antagonist, for idiopathic pulmonary fibrosis utilizing physiologically relevant stem cell-derived lung organoids
    Yamamoto, Yuki
    Nagamoto, Tetsuharu
    Choi, Harry
    Ito, Shunsuke
    Kishihata, Masako
    Iwase, Noriaki
    Arai, Kenichi
    Kojima, Masahiro
    Nishikawa, Kenji
    Okanari, Eiji
    Shinohara, Yuuko
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [22] Sildenafil inhibit dose-dependently profibrotic and remodelling effects of TGFβ1 on pulmonary arteries from patients with idiopathic pulmonary fibrosis (IPF)
    Juan, Gustavo
    Milara, Javier
    Ortiz, Jose Luis
    Escriva, Juan
    Ramon, Mercedes
    Fernandez, Estrella
    Cortijo, Julio
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [23] Effects of bosentan on oxygen pulse oximetry (SpO2) during exercise in idiopathic pulmonary fibrosis (IPF) patients: The build 1 study
    Brown, Kevin K.
    Behr, Juergen
    du Bois, Ron M.
    Raghu, Ganesh
    King, Tamadge E.
    CHEST, 2006, 130 (04) : 151S - 152S
  • [24] Inhibition of Profibrotic Signaling in Primary Fibroblasts from Patients with Idiopathic Pulmonary Fibrosis (IPF) by Sirtuin-1/-2-Inhibitor Sirtinol
    Korfei, M.
    Zlotkowski, J. V.
    Stelmaszek, D.
    Ruppert, C.
    Seeger, W.
    Guenther, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [25] Hospitalization of patients with idiopathic pulmonary fibrosis (IPF) in a phase 3, randomized, double-blind, placebo-controlled trial of interferon gamma-1B (IFN-γ1B)
    Bradford, WZ
    Starko, K
    Noble, PW
    CHEST, 2003, 124 (04) : 193S - 193S
  • [26] Analysis Of Pooled Data From 3 Phase 3, Multinational, Randomized, Double-Blind, Placebo Controlled Trials Evaluating Pirfenidone In Patients With Idiopathic Pulmonary Fibrosis (ipf)
    Noble, P. W.
    Albera, C.
    Bradford, W. Z.
    Costabel, U.
    du Bois, R. M.
    Fagan, E. A.
    Fishman, R.
    Glaspole, I.
    Glassberg, M. K.
    Lancaster, L.
    Lederer, D. J.
    Leff, J. A.
    Nathan, S. D.
    Pereira, C. A.
    Sahn, S. A.
    Swigris, J. J.
    Valeyre, D.
    King, T. E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [27] The Effects of Transforming Growth Factor-beta1 (TGF-β1) and Fibroblast Growth Factor-2 (FGF-2) on Proliferation of Fibroblasts from Lungs of Patients with Idiopathic Pulmonary Fibrosis (IPF).
    Khalil, N.
    Xu, Y. D.
    O'Connor, R.
    Behzad, H.
    Liu, X.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [28] Interim Analysis of Human Autologous Lung Stem Cell Transplant for Idiopathic Pulmonary Fibrosis (HALT- IPF): A First-in-Human, Phase 1, Randomized Controlled, Open-label Trial
    Cheng, K.
    Lobo, L. J.
    Ghodsi, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [29] TGF-β1, pSmad-2/3, Smad-7, and β-Catenin Are Augmented in the Pulmonary Arteries from Patients with Idiopathic Pulmonary Fibrosis (IPF): Role in Driving Endothelial-to-Mesenchymal Transition (EndMT)
    Gaikwad, Archana Vijay
    Eapen, Mathew Suji
    Dey, Surajit
    Bhattarai, Prem
    Shahzad, Affan Mahmood
    Chia, Collin
    Jaffar, Jade
    Westall, Glen
    Sutherland, Darren
    Singhera, Gurpreet Kaur
    Hackett, Tillie-Louise
    Lu, Wenying
    Sohal, Sukhwinder Singh
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (04)
  • [30] ENV-101, A Novel Hedgehog Inhibitor, Increases Lung Function, and Reduces Lung Fibrosis in Patients With Idiopathic Pulmonary Fibrosis: Results From a Randomized, Double- blind, Placebo-controlled Phase 2 Trial
    Maher, T. M.
    Goldin, J. G.
    DiFrancesco, A.
    de los Rios, M.
    Quito, C.
    Kim, S.
    Frohna, P. A.
    Hood, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
1234